FDA Investigator: Leslie D. Wagner
- Leslie D. Wagner first started conducting FDA inspections in 2017, with the last inspection in 2022. Over that time, Leslie D. Wagner has conducted 6 inspections at 5 companies across 4 sites.
Get Leslie Wagner's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Sanofi Pasteur Limited, North York | 2022
Out-of-stock
Leslie D. Wagner
Biologics Form 483
FDA 483 MassBiologics, Boston | 2019
Out-of-stock
Leslie D. Wagner
Biologic Form 483
FDA 483 Sanofi Pasteur Limited - Cannaught Campus, North York | 2019
Out-of-stock
Leslie D. Wagner
Biologic Form 483
FDA 483 GlaxoSmithKline Biologicals SA, Rixensart | 2019
Out-of-stock
Leslie D. Wagner
Biologic Form 483
FDA 483 Sanofi Pasteur Limited - Cannaught Campus, North York | 2017
Out-of-stock
Leslie D. Wagner
Biologic Form 483
Co-Investigators (13)
- Roger F. Zabinski, FDA Investigator
- Susan M. Jackson, FDA Investigator
- Eric Peng, FDA Investigator
- Janet L. Bowen, FDA Investigator
- Debra M. Emerson, FDA Investigator
- Lindsey R. Lyman, FDA Investigator
- Donald L. Lech, FDA Investigator
- Anita Verma, FDA Investigator
- Joan Johnson, FDA Investigator
- Shuang Tang, FDA Investigator
- Gene D. Arcy, FDA Investigator
- Omotunde O. Osunsanmi, FDA Investigator
- Christian J. Sauder, FDA Investigator